147 related articles for article (PubMed ID: 19882233)
1. Statin prescribing in Northern Ireland and England pre and post introduction of the quality and outcomes framework.
Alabbadi I; Crealey G; Turner K; Rafferty T; Keenan L; Murray P; McElnay JC
Pharm World Sci; 2010 Feb; 32(1):43-51. PubMed ID: 19882233
[TBL] [Abstract][Full Text] [Related]
2. Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications.
McGinn D; Godman B; Lonsdale J; Way R; Wettermark B; Haycox A
Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):73-85. PubMed ID: 20121565
[TBL] [Abstract][Full Text] [Related]
3. Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland.
Bennie M; Godman B; Bishop I; Campbell S
Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):125-30. PubMed ID: 22280202
[TBL] [Abstract][Full Text] [Related]
4. How has fundholding in Northern Ireland affected prescribing patterns? A longitudinal study.
Rafferty T; Wilson-Davis K; McGavock H
BMJ; 1997 Jul; 315(7101):166-70. PubMed ID: 9251548
[TBL] [Abstract][Full Text] [Related]
5. Achievement of cholesterol targets and prescribing of higher-cost statins: a cross-sectional study in general practice.
Fleetcroft R; Schofield P; Duerden M; Ashworth M
Br J Gen Pract; 2012 Dec; 62(605):e815-20. PubMed ID: 23211261
[TBL] [Abstract][Full Text] [Related]
6. Twenty-Year Nationwide Trends in Statin Utilization and Expenditure in Denmark.
Mortensen MB; Falk E; Schmidt M
Circ Cardiovasc Qual Outcomes; 2017 Jul; 10(7):. PubMed ID: 28698192
[No Abstract] [Full Text] [Related]
7. Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis.
Fleetcroft R; Schofield P; Ashworth M
BMC Health Serv Res; 2014 Sep; 14():414. PubMed ID: 25240604
[TBL] [Abstract][Full Text] [Related]
8. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
Yeh JS; Franklin JM; Avorn J; Landon J; Kesselheim AS
JAMA Intern Med; 2016 Jun; 176(6):763-8. PubMed ID: 27159336
[TBL] [Abstract][Full Text] [Related]
9. The influence of guidelines on the use of statins: analysis of prescribing trends 1998-2002.
Teeling M; Bennett K; Feely J
Br J Clin Pharmacol; 2005 Feb; 59(2):227-32. PubMed ID: 15676046
[TBL] [Abstract][Full Text] [Related]
10. Quality and efficiency of statin prescribing across countries with a special focus on South Africa: findings and future implications.
Godman B; Bishop I; Campbell SM; Malmström RE; Truter I
Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):323-30. PubMed ID: 25338546
[TBL] [Abstract][Full Text] [Related]
11. Did NICE guidelines and the Quality Outcomes Framework change GP antidepressant prescribing in England? Observational study with time trend analyses 2003-2013.
Kendrick T; Stuart B; Newell C; Geraghty AW; Moore M
J Affect Disord; 2015 Nov; 186():171-7. PubMed ID: 26241666
[TBL] [Abstract][Full Text] [Related]
12. Evolution of statin prescribing 1994-2001: a case of agism but not of sexism?
DeWilde S; Carey IM; Bremner SA; Richards N; Hilton SR; Cook DG
Heart; 2003 Apr; 89(4):417-21. PubMed ID: 12639870
[TBL] [Abstract][Full Text] [Related]
13. Statin prescribing in the elderly in the Netherlands: a pharmacy database time trend study.
Geleedst-De Vooght M; Maitland-van der Zee AH; Schalekamp T; Mantel-Teeuwisse A; Jansen P
Drugs Aging; 2010 Jul; 27(7):589-96. PubMed ID: 20583852
[TBL] [Abstract][Full Text] [Related]
14. The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium.
Fraeyman J; Van Hal G; Godman B; Beutels P
Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):141-51. PubMed ID: 23402454
[TBL] [Abstract][Full Text] [Related]
15. Price versus clinical guidelines in primary care statin prescribing: a retrospective cohort study and cost simulation model.
De Zarate MO; Mentzakis E; Fraser SD; Roderick P; Rutter P; Ornaghi C
J R Soc Med; 2022 Mar; 115(3):100-111. PubMed ID: 34793261
[TBL] [Abstract][Full Text] [Related]
16. Physical health indicators in major mental illness: analysis of QOF data across UK general practice.
Martin JL; Lowrie R; McConnachie A; McLean G; Mair F; Mercer SW; Smith DJ
Br J Gen Pract; 2014 Oct; 64(627):e649-56. PubMed ID: 25267051
[TBL] [Abstract][Full Text] [Related]
17. The impact of changes in national prescribing conditions for statins on their public expenditure and utilization in the Czech Republic 1997-2013.
Fuksa L; Vocelka M; Vytrisalova M
Health Policy; 2015 Sep; 119(9):1255-64. PubMed ID: 25929214
[TBL] [Abstract][Full Text] [Related]
18. A comparison of three methods of setting prescribing budgets, using data derived from defined daily dose analyses of historic patterns of use.
Maxwell M; Howie JG; Pryde CJ
Br J Gen Pract; 1998 Aug; 48(433):1467-72. PubMed ID: 10024703
[TBL] [Abstract][Full Text] [Related]
19. Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? A cross-sectional analysis of English primary care prescribing data.
Goldacre B; Reynolds C; Powell-Smith A; Walker AJ; Yates TA; Croker R; Smeeth L
BMJ Open; 2019 Feb; 9(2):e026886. PubMed ID: 30813120
[TBL] [Abstract][Full Text] [Related]
20. Developing prevalence-based prescribing units for analysing variations in general practitioner prescribing: a case study using statins.
Ward PR; Noyce PR; St Leger AS
J Clin Pharm Ther; 2003 Feb; 28(1):23-9. PubMed ID: 12605615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
